key: cord-0923862-u762x2eh authors: Holland, Matthew; Burke, Joseph; Hulac, Steven; Morris, Michael; Bryskiewicz, Gary; Goold, Audrey; McVaney, Kevin; Rappaport, Lara; Stauffer, Brian L. title: Excess Cardiac Arrest in the Community during the COVID-19 Pandemic date: 2020-06-13 journal: JACC Cardiovasc Interv DOI: 10.1016/j.jcin.2020.06.022 sha: 91b2d98134e990948b90beac571e5f853bb5349f doc_id: 923862 cord_uid: u762x2eh nan presentations for acute cardiac catheterization laboratory activations across a consortium of high volume primary percutaneous intervention centers correlating to the implementation of nationwide social distancing recommendations 1, 2 . Multiple theories have been proposed to explain this observation, ranging from a true decrease in the occurrence of acute coronary syndromes to a response to altered ambulatory care and adherence to strict social distancing guidelines 3 . To evaluate this issue, we queried the Denver Health Paramedic Division (DHPD) database before and after the emergence of COVID-19. DHPD is the sole emergency medical services (EMS) provider for the city and county of Denver and surrounding communities. We Historically most OHCA are related to myocardial ischemia 5 , however in the setting of the pandemic, it is possible that complications of COVID-19 are responsible, i.e following respiratory failure or myopericarditis. Unfortunately, during this timeframe COVID-19 testing was not widely available, but it is interesting to note that the excess OHCA was greater than the number of individuals that died with a COVID-19 diagnosis during the same time frame. An alternate unifying hypothesis for decreased hospital STEMI volume, regionally 1 , internationally 2 , and locally (personal communication) and these data is an increased incidence of myocardial infarction-related OHCA. Across-the-board restrictions on non-emergent procedures enacted by states, hospitals, and cardiovascular society guidelines may lead to delays in diagnosis and definitive treatment. Finally, patient fear of contracting COVID-19 while seeking care may lead to avoidance of life saving therapies. A review at the patient level is essential to obtain a more granular understanding of these data. However, in the interim, providers should consider the unintended consequence of the pandemic response in the context of chronic and emergent cardiovascular disease. One possibility suggested by our data is that patients with acute coronary syndromes are not presenting for care resulting in an increase in OHCA. ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Impacto de la pandemia de COVID-19 sobre la actividad asistencial en cardiología intervencionista en España Where Have All the Heart Attacks Gone CSDF State-specific mortality from sudden cardiac death--United States